SCHEMBL5215922

SCHEMBL5215922

[CH2]Cc1cccc(-c2ccc(F)nc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 3/20 0.42
CYP2E1 P05181 1/20 0.41
CYP2A6 P11509 1/20 0.41
CYP2B6 P20813 1/20 0.41
GRIN1 Q05586 5/20 0.39
GRIN2B Q13224 5/20 0.39
TAAR1 Q96RJ0 2/20 0.39
AGXT P21549 1/20 0.38
CYP11B1 P15538 2/20 0.38
MAP4K4 O95819 1/20 0.38
CYP17A1 P05093 1/20 0.37
CYP3A4 P08684 1/20 0.37
GRM5 P41594 1/20 0.37
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
EPHX2 P34913 1/20 0.36
PRMT6 Q96LA8 1/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675747 0.83 PRKCI (0.53) CYP11B2CYP2E1CYP2A6CYP2B6
SCHEMBL24721758 0.83 BCL2 (0.47) CYP11B2CYP2E1CYP2A6CYP2B6GRIN1
SCHEMBL5675196 0.81 TAAR1 (0.55) CYP11B2TAAR1DRD2
SCHEMBL19497005 0.80 TAAR1 (0.45) CYP11B2CYP2E1CYP2A6CYP2B6GRIN1
SCHEMBL21410258 0.77 CYP11B2 (0.45) CYP11B2CYP2E1CYP2A6CYP2B6GRIN1
SCHEMBL5677385 0.77 EPHB4 (0.46) MAP4K4SRCWNT3A
SCHEMBL13680797 0.77 CYP11B2 (0.38) CYP11B2CYP2E1CYP2A6CYP2B6GRIN1
SCHEMBL13680468 0.74 GRIN1 (0.53) CYP11B2CYP2E1CYP2A6CYP2B6GRIN1
SCHEMBL30098552 0.74 MAP4K4 (0.68) CYP11B2CYP2E1CYP2A6CYP2B6TAAR1
SCHEMBL4700834 0.74 MAP4K4 (0.68) CYP11B2CYP2E1CYP2A6CYP2B6TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581516-A4 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL MYERS SQUIBB CO (US) 2007-10-17 EP claimed
EP-1581516-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-10-05 EP claimed
WO-2004047744-A2 3-HETEROCYCLIC BENZYLAMIDE DERIVATIVES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 WO claimed